Strategy & Management

Magazine articles on business strategy, management and leadership.

Old Articles: <Older 6511-6520 Newer>

The Motley Fool November 14, 2005 Rich Duprey	Escala's Smart Acquisitions The collectibles company continues to grow on the strength of buyouts that play to its strengths. Investors, take note.
The Motley Fool November 14, 2005 Rick Aristotle Munarriz	EA at Your Service Electronic Arts gets into the digital distribution game. It's a logical move for the world's leading video game maker. Investors, take note.
Pharmaceutical Executive October 1, 2005	Successful Alliances: Novartis and Idenix Share the Secrets of Success Novartis Pharma AG CEO Thomas Ebeling and Idenix founder, CEO, and chairman Jean-Pierre Sommadossi discuss the mutual benefits and challenges of maintaining a successful partnership.
Pharmaceutical Executive October 1, 2005 Numero & Nightingale	Seven Principles for Fostering Partnerships Senior pharma executives who are serious about engineering dramatic improvements in the way their companies do business development should consider these fundamental principles that are vital for success.
Pharmaceutical Executive October 1, 2005 Alana Klein	Ad Agencies to the Rescue Faced with strict guidelines and regulatory pressures over advertising, pharmaceutical clients are looking to their agencies for support and guidance.
Pharmaceutical Executive October 1, 2005 Jeffrey D. Abbey	Considering Intangibles Biotech partnerships among scientists, academic institutions, and pharma companies provide many challenges, including identifying the right partners, developing strong relationships to overcome hurdles, and dealing with cultural differences in an increasingly global market.
Pharmaceutical Executive October 1, 2005 Fine & Meyer	An 11-Step Program to Navigating Partnerships Commercial partnerships are an effective way to differentiate both research institutes and biotech companies. It is critical to recognize that while financial return is the primary driver of a commercial partnership, the cultural fit can sustain its success.
Pharmaceutical Executive October 1, 2005 Mark J. Ahn	It's All Academic: Biotechs Looking to Universities Pharmaceuticals and academic institutions are forming alliances at an increasing rate to exploit the promise of emerging biological insights.
Pharmaceutical Executive October 1, 2005 Joseph S. Dillon	Risks and Rewards: How to Protect the Hand You're Dealt Like each bet at the gaming table, the wagers and payoffs of pharma deals must be condsidered on their own merits, using careful due diligence to achieve a beneficial deal structure.
Pharmaceutical Executive October 1, 2005 Brad Miles	Value Today for Drugs Tomorrow The industry can help its bad rep by communicating the promise of its pipeline -- and the value of its companies.
<Older 6511-6520 Newer> Return to current articles.